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EDITORIAL COMMENT
Air Pollution as a
Cause of Heart Disease
Time for Action*
Stanton A. Glantz, PHD, FACC
San Francisco, California
The environmental controls that have been developed over
the last quarter century have, for the most part, been
designed to reduce respiratory disease and cancer. In con-
trast, public health measures designed to reduce heart
disease have concentrated on individual risk factors (1).
Over the last decade, however, there has been growing
epidemiological evidence that elevated levels of air pollu-
tion, particularly increased levels of fine particulates (smaller
than 10 m in diameter, PM10 or 2.5 m, PM2.5), are
associated with increased hospitalization (2) and mortality
from cardiovascular disease (3–5).
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The study by Suwa et al. (6) in this issue of the Journal
provides important experimental evidence to support the
conclusion that these epidemiological results are reflecting
real effects of particulate pollution directly on the cardio-
vascular system. The investigators present convincing exper-
imental evidence that particulate air pollution induces pro-
gression of atherosclerosis. They exposed rabbits to small
particles (most 3 m) collected from outdoor air in
Ottawa, Canada by intrapharyngeal installation twice a
week for four weeks, then measured responses in the lung,
bone marrow, coronary arteries and aorta. The delivered
dose at the level of the alveolar surface, estimated to be 23.2
ng/cm2, was less than the estimated human exposure of 35.1
ng/cm2 based on average pollution levels in six U.S. cities
(3). Compared to a control group, the rabbits exposed to the
particles from the air pollution experienced a systemic
inflammatory response that included bone marrow stimula-
tion and progression of atherosclerotic lesions in the coro-
nary arteries and aorta. The extent of the atherosclerotic
effects correlated with the extent of particulates phagocy-
tosed by alveolar macrophages in the lung. The rabbits
exposed to particulates had more advanced phenotypes of
coronary lesions and increased plaque size. There was
histological evidence of more extensive atherosclerosis in the
aorta, an increase in the volume fraction of the lesions made
up of lipids, and increased cell turnover. Plaques with these
characteristics are more likely to rupture and trigger a
coronary event than collagenous plaques (7,8).
The results reported by Suwa et al. (6) are consistent with
human studies that found elevated levels of C-reactive
protein, a marker of systemic inflammation, in people
during times of increased particulate air pollution (9,10).
During increased levels of particulate air pollution, individ-
uals experience elevated levels of plasma viscosity (11) and
other changes in blood chemistry, suggesting that the
adhesive properties of red blood cells are increased (10).
These changes would predict an increased risk of a coronary
event during periods of heightened air pollution.
Further support that these changes are due to the effects
of air pollution comes from studies of the effects of second-
hand tobacco smoke, which is, after all, indoor air pollution.
Even short-term exposure to secondhand smoke increases
platelet activation (12,13). Secondhand smoke also pro-
motes atherosclerosis (14–16). This effect does not depend
on the nicotine in the smoke (17), further implicating
general products of combustion of organic matter, similar to
those products observed in outdoor air pollution. The fact
that exposure to the secondhand smoke of just one cigarette
a day accelerated the atherosclerotic process (15) also
suggests that low doses of air pollutants can have important
effects on the coronary circulation. Other organic pollutants,
7,12-dimethylbenz(a)anthracene (18) and 1,3-butadiene
(19), are atherogenic in experimental animals exposed via
inhalation.
Although the precise mechanisms by which exposure to
particulates affects the autonomic nervous system are un-
clear, there is strong and consistent evidence that increases
in the level of particulate air pollution are associated with
reduced heart rate variability (20,21) and increases in heart
rate (22) and blood pressure (23,24). Decreased heart rate
variability predicts a higher risk of cardiac death or arrhyth-
mic events after acute myocardial infarction (MI), presum-
ably reflecting the adverse effects of increased sympathetic
tone (25,26). In addition to epidemiological evidence that
increased air pollution produces these effects, similar
changes were observed in a quasi-experimental study of
boilermakers, which found that significant reductions in
heart rate variability were associated with just a few hours of
occupational exposure to increased particulate levels (27).
Likewise, an experimental study of the effects of secondhand
smoke on heart rate variability showed an average 12%
reduction in heart rate variability after just 2 h of exposure
in an airport smoking lounge (28). A study of 100 patients
with implanted cardioverter-defibrillators (ICDs) observed
a higher rate of discharges within two days of periods of
elevated air pollution (NO, CO, fine carbon, and fine
particulates), indicating an increased incidence of poten-
tially life-threatening arrythmias (29).
Secondhand smoke exposures produce rapid (in 30 min in
human studies) deterioration in endothelial function in
experimental animals (30) and humans (31–33). Second-
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hand smoke also increases infarct size in experimental
animals (16), an effect that can be partially blocked by
administering L-arginine, which helps restore endothelial
function (34). To date, there have not been studies of the
effects of air pollution on endothelial function, but it is likely
that some of the effects observed in the epidemiological
studies are due to the influence of air pollution on endo-
thelial function. This is a question worthy of future research.
Finally, increases in air pollution are associated with
increased risk of MI (29,35). A study in Boston reported
that these effects occur quickly; the odds of an MI were
significantly increased (odds ratio [OR]  1.48, 95%
confidence interval [CI], 1.09–2.02) with an incr]ease in
airborne particulate concentrations of 25 g/m3 during the
2-h period before the onset of the MI and an OR of 1.69
(95% CI, 1.13–2.34) for an increase of 20 g/m3 in the 24 h
before event onset (29).
All these effects indicate that air pollution has an impact
on heart disease. Some of these effects may occur over time,
as with acceleration of the progression of atherosclerosis, or
very quickly, as with an increase in the risk of an arrhythmia
or MI by acute inflammatory responses, altering platelet
function, or, perhaps, endothelial function. These effects
may be independent of, or synergistic with, alterations in
autonomic tone as reflected in increases in heart rate and
reductions in heart rate variability.
In any event, it is clear that these risks are real and
substantial. Indeed, of the estimated 53,000 deaths due to
secondhand smoke, 37,000 are attributed to cardiovascular
disease compared with only 3,000 attributed to lung cancer
(12). (Other estimates put the cardiovascular death estimate
as high as 62,000 [36].) If outdoor air pollution exhibits a
similar pattern of risks, the toll due to heart disease could be
much larger—and more immediate—than the burden of
cancer and lung disease that has been used to develop
current air pollution standards.
It is time for organizations concerned with heart health,
including the American College of Cardiology and the
American Heart Association, as well as traditional environ-
mental organizations and environmental regulators, to con-
sider seriously the cardiovascular effects of air pollution
when developing and implementing standards to clear the
air and protect public health.
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